Tradestie Institutional Equity Comparison Engine
CANC vs DSPY โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DSPY Overall Edge
DSPY Captures Institutional Edge (1โ0 Pillars ยท 3โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DSPY (DSPY) driven by superior Momentum & Technical. Fundamentally, CANC trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus DSPY at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, CANC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DSPY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
CANC N/M vs DSPY N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
DSPY
1Y +22.7% vs +13.2% ยท 52W Pos 52% vs 73%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
CANC
NASDAQ
Tema Oncology ETF
Institutional Equity
$40.26
-1.95% 1D
Market Cap
N/A
1M Return
+1.55%
1Y Return
+22.71%
Forward P/E
N/M
Unified AI Score
48.5 / 100
HOLD
Tech 43.0
Fund 48.0
Flow 50.0
Mom 56.0
DSPY
US Equity
DSPY
Institutional Equity
$64.97
-1.71% 1D
Market Cap
N/A
1M Return
-1.62%
1Y Return
+13.23%
Forward P/E
N/M
Unified AI Score
52.1 / 100
HOLD
Tech 47.0
Fund 52.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CANC +22.71%
DSPY +13.23%
Spread: +9.48 pp (CANC Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
CANC TTM Op. Margin: N/A
DSPY TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CANC vs DSPY. Trailing 12-month operating profitability (CANC N/A vs DSPY N/A) and valuation multiples (CANC N/M vs DSPY N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CANC | DSPY | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 52% ($33โ$47) | 73% ($56โ$68) | Stronger Trend | DSPY |
| Beta / 30D Volatility Risk Regime | 0.89ฮฒ ยท 33% Vol | 0.90ฮฒ ยท 21% Vol | Lower Realized Risk | DSPY |
| Unified Institutional Score Composite Signal | 48.5 / 100 (HOLD) | 52.1 / 100 (HOLD) | Higher Composite | DSPY |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CANC vs DSPY Buy Guide
CANC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
DSPY
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CANC nor DSPY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.